Deniz Tural
Impact in
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Gastric Cancer Management and Outcomes
- Sarcoma Diagnosis and Treatment
- Metastasis and carcinoma case studies
- Renal cell carcinoma treatment
Papers in
- Oncology 57
- Cancer Immunotherapy and Biomarkers 17
- Colorectal Cancer Treatments and Studies 11
-
- Renal cell carcinoma treatment 18
- Gastric Cancer Management and Outcomes 16
- Metastasis and carcinoma case studies 11
- Prostate Cancer Treatment and Research 10
- Co-authors
- Fatih SelçukbırıcıkSüheyla SerdengeçtiHasan MutluEvin BüyükünalHasan Şenol ÇoşkunNil Molinas MandelMükremın UysalÖzcan Yıldız
- Journals
- Journal of Clinical Oncology (11 papers)Clinical Genitourinary Cancer (6 papers)Tumor Biology (3 papers)International Journal of Clinical Oncology (3 papers)Japanese Journal of Clinical Oncology (2 papers)
- Partner nations
- TürkiyeUnited StatesSpain
In The Last Decade
Deniz Tural
106 papers receiving 920 citations
Peers
Comparison fields: 5 of 82
- Oncology 478
- Pulmonary and Respiratory Medicine 377
- Otorhinolaryngology 44
- Cancer Research 143
- Gastroenterology 52
Countries citing papers authored by Deniz Tural
This map shows the geographic impact of Deniz Tural's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deniz Tural with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deniz Tural more than expected).
Fields of papers citing papers by Deniz Tural
This network shows the impact of papers produced by Deniz Tural. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deniz Tural. The network helps show where Deniz Tural may publish in the future.
Co-authors
The 25 scholars most cited alongside Deniz Tural, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 0 | |
| 9 | PTEN loss is a predictive marker for HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies. | 2020 | 5 |
| 10 | 2020 | 2 | |
| 11 | Receptor discordances after neoadjuvant chemotherapy and their effects on survival. | 2019 | 16 |
| 12 | 2018 | 13 | |
| 13 | 2018 | 5 | |
| 14 | Complete response to crizotinib in a patient with adenocarcinoma of the lung cancer harboring c- MET amplification. | 2017 | 5 |
| 15 | What are the optimal treatment modalities according to age group in gastric cancer patients? | 2017 | 3 |
| 16 | Is there any relation between PET-CT SUVmax value and prognostic factors in locally advanced breast cancer? | 2016 | 14 |
| 17 | 2014 | 5 | |
| 18 | 2012 | 11 | |
| 19 | 2011 | 14 | |
| 20 | 2010 | 6 |
About Deniz Tural
Deniz Tural is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Gastroenterology, Cancer Research and Otorhinolaryngology, having authored 121 papers that have together received 938 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (18 papers), Cancer Immunotherapy and Biomarkers (17 papers), Gastric Cancer Management and Outcomes (16 papers), Bladder and Urothelial Cancer Treatments (12 papers), Metastasis and carcinoma case studies (11 papers), Colorectal Cancer Treatments and Studies (11 papers), Prostate Cancer Treatment and Research (10 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Oncology (478 citations), Pulmonary and Respiratory Medicine (377 citations), Otorhinolaryngology (44 citations), Cancer Research (143 citations) and Gastroenterology (52 citations). Deniz Tural has collaborated with scholars based in Türkiye, United States and Spain. Frequent co-authors include Fatih Selçukbırıcık, Süheyla Serdengeçti, Hasan Mutlu, Evin Büyükünal, Hasan Şenol Çoşkun, Nil Molinas Mandel, Mükremın Uysal, Özcan Yıldız, Sibel Erdamar and Şeyda Gündüz. Their work appears in journals such as Journal of Clinical Oncology, Clinical Genitourinary Cancer, Tumor Biology, International Journal of Clinical Oncology and Japanese Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.